Actinomycosis

Infectious Disease MONDO:0005631 Pathograph 25 Show in embeddings browser primary bacterial infectious disease

Actinomycosis is a rare, chronic, suppurative and granulomatous bacterial infection caused by endogenous Actinomyces species after disruption of the oral, gastrointestinal, or genital mucosal barrier. The anaerobic, filamentous Gram-positive organisms survive phagocytosis, form sulfur-granule lesions with necrosis and chronic inflammation, spread contiguously across tissue planes, form abscesses and sinus tracts, and often mimic malignancy in cervicofacial, pulmonary, abdominopelvic, or central nervous system sites. Prolonged high-dose beta-lactam therapy kills Actinomyces by inhibiting peptidoglycan cross-linking, and surgical resection or drainage is used for bulky, necrotic, or anatomically complicated disease.

Ask OpenScientist

Ask a research question about Actinomycosis. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

8
Pathophys.
12
Phenotypes
25
Pathograph
3
Medical Actions
4
Subtypes
6
References
1
Deep Research
🏷

Classifications

Harrison's Part
INFECTIOUS DISEASES
◆

Subtypes

4
Cervicofacial actinomycosis MONDO:0005699
The classic dental-focus form, often arising after odontogenic infection or dental procedures and presenting as a mandibular, maxillary, or neck mass with possible sinus-tract drainage and mandibular osteomyelitis.
Show evidence (1 reference)
PMID:25045274 SUPPORT REVIEW SYNTHESIS Human Clinical
"cervicofacial actinomycosis following dental focus of infection"
The review identifies the cervicofacial form and its usual dental focus.
Pulmonary or thoracic actinomycosis
Thoracic infection linked to aspiration and poor dental hygiene; it can mimic lung cancer with mass-like or cavitary lesions and symptoms such as cough, dyspnea, fever, hemoptysis, malaise, and weight loss.
Show evidence (1 reference)
PMID:25045274 SUPPORT REVIEW SYNTHESIS Human Clinical
"pulmonary actinomycosis in smokers with poor dental hygiene"
The review identifies the pulmonary form and a characteristic dental-hygiene risk context.
Abdominal and pelvic actinomycosis
Infection of gastrointestinal or genital sites after a mucosal lesion or long-standing intrauterine device use; abdominal and pelvic cases can resemble inflammatory bowel disease or pelvic and colonic malignancy.
Show evidence (2 references)
PMID:24905109 SUPPORT Human Clinical
"The clinical presentation of abdominal actinomycosis shows a great variability and it often mimics other intraabdominal pathologies like chronic inflammatory bowel diseases or malignancies."
The case report abstract characterizes the abdominal presentation and its malignancy/IBD mimicry.
PMID:42287450 SUPPORT Human Clinical
"Pelvic actinomycosis is a rare, chronic infection caused by Actinomyces species, most associated with prolonged intrauterine device (IUD) use."
The retrospective case series and literature review characterize the IUD-associated pelvic form.
Central nervous system actinomycosis
A rare severe form of actinomycosis involving the brain, meninges, or spinal epidural space. A systematic review found brain abscess to be the most common neuroimaging finding and reported meaningful fatality and neurological sequelae rates.
Show evidence (1 reference)
PMID:37269006 SUPPORT Human Clinical
"Brain abscess (55%) followed by leptomeningeal enhancement (22%) were the most common neuroimaging findings."
The 118-case systematic review defines brain abscess as the dominant CNS presentation.
⚙

Pathophysiology

8
Mucosal Barrier Breach and Endogenous Inoculation
Actinomyces species normally colonize oral, gastrointestinal, and genital mucosa. Dental foci, aspiration-prone poor oral hygiene, long-standing intrauterine devices, surgery, or trauma can disrupt the barrier and seed organisms into anaerobic deep tissue.
epithelial cell CL:0000066 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves epithelial cell (CL:0000066). CL:0000066 is a cell type from the Cell Ontology.
response to bacterium GO:0009617 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves response to bacterium (GO:0009617). GO:0009617 is a biological process from the Gene Ontology.
Downstream
Intracellular Persistence in Phagocytes After inoculation into deep tissue, Actinomyces are phagocytosed but survive intracellularly, establishing a chronic focus.
Show evidence (2 references)
PMID:25045274 SUPPORT REVIEW SYNTHESIS Human Clinical
"anaerobic Gram-positive bacteria that normally colonize the human mouth and digestive and genital tracts."
Establishes that the pathogens are endogenous mucosal colonists.
PMID:24905109 SUPPORT Human Clinical
"require a mucosal lesion to cause an opportunistic infection."
Establishes that a mucosal barrier lesion is needed for opportunistic invasion.
Intracellular Persistence in Phagocytes
Although Actinomyces are phagocytosed by host cells, they are not killed and behave as facultative intracellular parasites. This failure of intracellular clearance is a proposed reason the infection becomes chronic rather than resolving.
macrophage CL:0000235 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves macrophage (CL:0000235). CL:0000235 is a cell type from the Cell Ontology.
Downstream
Suppurative Granulomatous Sulfur-Granule Inflammation Persistent intracellular and deep-tissue organisms drive the chronic suppurative granulomatous response that forms sulfur granules.
Show evidence (1 reference)
PMID:2228706 SUPPORT BACKGROUND Human Clinical
"The organism, although phagocytized by the host cells, is not killed."
States that Actinomyces survive phagocytosis, the basis for chronic persistence.
Suppurative Granulomatous Sulfur-Granule Inflammation
Deep-tissue Actinomyces infection produces necrosis with yellow sulfur granules containing filamentous Gram-positive organisms and a chronic granulomatous inflammatory reaction. Splendore-Hoeppli material can form around the bacteria as part of the localized antigen-antibody-rich response.
neutrophil CL:0000775 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves neutrophil (CL:0000775). CL:0000775 is a cell type from the Cell Ontology. macrophage CL:0000235 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves macrophage (CL:0000235). CL:0000235 is a cell type from the Cell Ontology.
granuloma formation GO:0002432 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves granuloma formation (GO:0002432). GO:0002432 is a biological process from the Gene Ontology. inflammatory response GO:0006954 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves inflammatory response (GO:0006954). GO:0006954 is a biological process from the Gene Ontology.
Downstream
Abscess and Fistula Formation Chronic suppurative granulomatous inflammation coalesces into abscesses and fistulizing lesions.
Fever The chronic inflammatory response produces systemic fever.
Weight loss Chronic infection produces constitutional weight loss.
Abdominal pain Suppurative inflammation of gastrointestinal-site actinomycosis produces abdominal pain.
Show evidence (2 references)
PMID:25045274 SUPPORT REVIEW SYNTHESIS Human Clinical
"typical microscopic findings include necrosis with yellowish sulfur granules and filamentous Gram-positive fungal-like pathogens."
Describes the characteristic necrotic sulfur-granule histopathology.
PMID:18976399 SUPPORT Other
"The bacterial infections include botryomycosis, nocardiosis and actinomycosis."
Identifies actinomycosis as a bacterial cause of the Splendore-Hoeppli phenomenon.
Abscess and Fistula Formation
The persistent inflammatory focus organizes into abscesses and fistulas that can drain to skin or mucosal surfaces through sinus tracts.
inflammatory response GO:0006954 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves inflammatory response (GO:0006954). GO:0006954 is a biological process from the Gene Ontology.
Downstream
Contiguous Spread Across Tissue Planes Abscesses and fistulas extend across normal anatomic barriers rather than respecting them.
Abscess Suppurative lesions present clinically as abscesses.
Draining Sinus Tract Contiguous suppuration drains through sinus tracts.
Brain Abscess In the CNS form, abscess formation presents as brain abscess.
Show evidence (1 reference)
PMID:28684963 SUPPORT REVIEW SYNTHESIS Human Clinical
"Its symptomatology imitates some malignant pelvic tumours, tuberculosis, or nocardiosis, causing abscesses and fistulas."
The pelvic review reports abscess and fistula formation in actinomycosis.
Contiguous Spread Across Tissue Planes
Actinomycosis characteristically extends contiguously across fascial and anatomic planes, invading adjacent bone, pleura, and soft tissue rather than metastasizing.
inflammatory response GO:0006954 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves inflammatory response (GO:0006954). GO:0006954 is a biological process from the Gene Ontology.
Downstream
Mass Mimicking Malignancy Contiguous infiltration forms an indurated mass that clinically and radiologically resembles a tumor.
Reactive Fibrosis Chronic infiltration provokes reactive fibrosis in involved tissue.
Osteomyelitis Contiguous spread into adjacent bone produces osteomyelitis.
Pleural effusion Thoracic contiguous spread to the pleura produces pleural involvement and effusion.
Show evidence (1 reference)
PMID:25045274 SUPPORT REVIEW SYNTHESIS Human Clinical
"Cervicofacial actinomycosis could be associated with large abscesses and/or mandibular osteomyelitis with or without sinus tract"
Documents contiguous extension of cervicofacial disease into mandibular bone.
Mass Mimicking Malignancy
The infiltrative inflammatory mass mimics malignancy at cervicofacial, pulmonary, abdominal, pelvic, and CNS sites, and is the reason actinomycosis is commonly mistaken for a tumor before tissue diagnosis. No suitably specific cross-site HP term exists for an infection-related infiltrative mass, so the mass is modeled as a mechanism node with site-specific mass and airway phenotypes bound below.
inflammatory response GO:0006954 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves inflammatory response (GO:0006954). GO:0006954 is a biological process from the Gene Ontology.
Downstream
Abdominal mass The infiltrative mass presents as a palpable abdominal mass in gastrointestinal-site disease.
Cough A pulmonary mass-forming lesion produces cough.
Dyspnea Pulmonary mass and consolidation produce dyspnea.
Hemoptysis Airway and parenchymal involvement produces hemoptysis.
Show evidence (2 references)
PMID:42717451 SUPPORT Human Clinical
"Actinomycosis is an uncommon chronic bacterial infection that may present as an infiltrative mass mimicking malignancy."
States that actinomycosis presents as an infiltrative mass mimicking malignancy.
PMID:25045274 SUPPORT REVIEW SYNTHESIS Human Clinical
"actinomycosis may mimic the malignancy process in various anatomical sites."
General review support for malignancy mimicry across sites.
Reactive Fibrosis
Chronic actinomycotic inflammation drives reactive fibrosis, producing the dense fibrotic lesions that can require excision.
fibroblast CL:0000057 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves fibroblast (CL:0000057). CL:0000057 is a cell type from the Cell Ontology.
Show evidence (1 reference)
PMID:42717451 SUPPORT Human Clinical
"associated with granulation tissue and reactive fibrosis"
Histopathology of an actinomycosis mass reports reactive fibrosis.
Actinomyces Peptidoglycan Cross-Linking (Beta-Lactam Target)
Actinomyces are bacteria with peptidoglycan cell walls. Penicillin and amoxicillin inhibit the penicillin-binding protein DD-transpeptidases that cross-link peptidoglycan, leaving growing organisms unable to maintain the load-bearing sacculus.
peptidoglycan-based cell wall biogenesis GO:0009273 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves peptidoglycan-based cell wall biogenesis (GO:0009273). GO:0009273 is a biological process from the Gene Ontology.
Show evidence (2 references)
PMID:22203377 SUPPORT Other
"Peptidoglycan synthesis requires glycosyltransferases (GTases) to polymerize the glycan chains and DD-transpeptidases (DD-TPases) to crosslink the peptides"
Establishes the conserved bacterial peptidoglycan cross-linking step that beta-lactams inhibit.
PMID:25045274 SUPPORT REVIEW SYNTHESIS Human Clinical
"penicillin G or amoxicillin are considered drugs of choice for the treatment of actinomycosis."
The Actinomyces-specific review establishes that penicillin G or amoxicillin, which act on this peptidoglycan cross-linking step, are the drugs of choice.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Actinomycosis Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

12
Digestive 1
Abdominal mass HP:0031500 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Abdominal mass (HP:0031500). HP:0031500 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:25045274 SUPPORT REVIEW SYNTHESIS Human Clinical
"patients with appendix, cecum, or colon actinomycosis frequently have abdominal pain with a palpable mass"
The review reports a palpable abdominal mass in gastrointestinal actinomycosis.
Immune 3
Abscess HP:0025615 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Abscess (HP:0025615). HP:0025615 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:28684963 SUPPORT REVIEW SYNTHESIS Human Clinical
"Its symptomatology imitates some malignant pelvic tumours, tuberculosis, or nocardiosis, causing abscesses and fistulas."
The pelvic systematic review describes abscess and fistula formation as part of actinomycosis.
Osteomyelitis HP:0002754 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Osteomyelitis (HP:0002754). HP:0002754 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:25045274 SUPPORT REVIEW SYNTHESIS Human Clinical
"Cervicofacial actinomycosis could be associated with large abscesses and/or mandibular osteomyelitis with or without sinus tract"
The review documents mandibular osteomyelitis in cervicofacial actinomycosis.
Brain Abscess HP:0030049 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Brain abscess (HP:0030049). HP:0030049 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:37269006 SUPPORT Human Clinical
"Brain abscess (55%) followed by leptomeningeal enhancement (22%) were the most common neuroimaging findings."
The systematic review of 118 CNS cases quantifies brain abscess frequency.
Integument 1
Draining Sinus Tract Draining sinus tract in skin HP:6000095 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Draining sinus tract in skin (HP:6000095). HP:6000095 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:25045274 SUPPORT REVIEW SYNTHESIS Human Clinical
"multiple abscesses with draining sinus tracts on the skin surface or oral mucosa"
The review directly states that draining sinus tracts form on skin or oral mucosa.
Metabolism 2
Fever HP:0001945 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Fever (HP:0001945). HP:0001945 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:42007821 SUPPORT Human Clinical
"patients commonly presented with cough, dyspnea, fever, hemoptysis, malaise, and weight loss."
The pulmonary case series and review lists fever among common presenting symptoms.
Pleural effusion HP:0002202 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Pleural effusion (HP:0002202). HP:0002202 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:25045274 SUPPORT REVIEW SYNTHESIS Human Clinical
"Pleural involvement, with thickening, effusion, or empyema"
The review documents pleural involvement including effusion in thoracic actinomycosis.
Respiratory 3
Cough HP:0012735 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cough (HP:0012735). HP:0012735 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:42007821 SUPPORT Human Clinical
"patients commonly presented with cough, dyspnea, fever, hemoptysis, malaise, and weight loss."
The pulmonary case series and review lists cough among common presenting symptoms.
Dyspnea HP:0002094 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Dyspnea (HP:0002094). HP:0002094 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:42007821 SUPPORT Human Clinical
"patients commonly presented with cough, dyspnea, fever, hemoptysis, malaise, and weight loss."
The pulmonary case series and review lists dyspnea among common presenting symptoms.
Hemoptysis HP:0002105 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hemoptysis (HP:0002105). HP:0002105 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:42007821 SUPPORT Human Clinical
"patients commonly presented with cough, dyspnea, fever, hemoptysis, malaise, and weight loss."
The pulmonary case series and review lists hemoptysis among common presenting symptoms.
Constitutional 1
Abdominal pain HP:0002027 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Abdominal pain (HP:0002027). HP:0002027 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:25045274 SUPPORT REVIEW SYNTHESIS Human Clinical
"patients with appendix, cecum, or colon actinomycosis frequently have abdominal pain with a palpable mass"
The review reports abdominal pain with a palpable mass in gastrointestinal actinomycosis.
Growth 1
Weight loss HP:0001824 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Weight loss (HP:0001824). HP:0001824 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:42007821 SUPPORT Human Clinical
"patients commonly presented with cough, dyspnea, fever, hemoptysis, malaise, and weight loss."
The pulmonary case series and review lists weight loss among common presenting symptoms.
💊

Medical Actions

3
Prolonged Penicillin or Amoxicillin Therapy
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
Agent: benzylpenicillin CHEBI:18208 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses benzylpenicillin (CHEBI:18208). CHEBI:18208 is a therapeutic agent from Chemical Entities of Biological Interest. amoxicillin CHEBI:2676 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses amoxicillin (CHEBI:2676). CHEBI:2676 is a therapeutic agent from Chemical Entities of Biological Interest.
Platform: Small molecule
Prolonged high-dose beta-lactam treatment with intravenous penicillin G or oral amoxicillin is the standard Actinomyces-directed antimicrobial strategy; courses usually last 6-12 months and may be shortened after complete surgical resection of infected tissue.
Mechanism Target:
Actinomyces Peptidoglycan Cross-Linking (Beta-Lactam Target) — Penicillin G and amoxicillin acylate bacterial penicillin-binding proteins and block peptidoglycan cross-linking in susceptible Actinomyces.
Show evidence (1 reference)
PMID:25045274 SUPPORT REVIEW SYNTHESIS Human Clinical
"Patients with actinomycosis require prolonged (6- to 12-month) high doses (to facilitate the drug penetration in abscess and in infected tissues) of penicillin G or amoxicillin"
Review support for prolonged high-dose penicillin G or amoxicillin therapy.
Surgical Resection or Drainage
Action: Surgical ProcedureNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Surgical Procedure (NCIT:C15329). NCIT:C15329 is a clinical intervention from the NCI Thesaurus. NCIT:C15329
Platform: Surgery
Surgery drains abscesses, removes necrotic or fibrotic infected tissue, and establishes a histologic diagnosis when actinomycosis mimics cancer; in CNS disease, surgery combined with antimicrobials is associated with better survival than antimicrobials alone.
Mechanism Target:
Reactive Fibrosis — Surgery excises bulky fibrotic or necrotic infected tissue.
Abscess and Fistula Formation — Surgery drains abscesses and marsupializes chronic sinus tracts.
Show evidence (2 references)
PMID:25045274 SUPPORT REVIEW SYNTHESIS Human Clinical
"the duration of antimicrobial therapy could probably be shortened to 3 months in patients in whom optimal surgical resection of infected tissues has been performed."
The review describes surgical resection as a way to reduce infected tissue burden and shorten antimicrobial therapy.
PMID:37269006 SUPPORT Human Clinical
"patients who underwent surgery with antimicrobials had better survival (adjusted OR 0.14, 95% CI 0.04-0.28, p value 0.039) compared to those treated with antimicrobials alone."
The CNS systematic review reports improved survival with combined surgery and antimicrobials.
Intrauterine device removal
In IUD-associated pelvic actinomycosis, removing the device eliminates the nidus of Actinomyces colonization; colonization clears after removal even without antibiotics.
Mechanism Target:
Mucosal Barrier Breach and Endogenous Inoculation — Removing the intrauterine device eliminates the chronic device-associated nidus that seeds pelvic Actinomyces colonization and invasion.
Show evidence (1 reference)
PMID:6529911 SUPPORT Human Clinical
"After removal of the IUCD, and without antibiotic therapy, in 100% (20/20) of the women, ALO colonisation was no longer found six to twelve months later."
Colonization cleared in all women after IUD removal, supporting removal as management.
🌍

Environmental Factors

2
Long-standing intrauterine device use
Prolonged intrauterine device (IUD) use is the best-quantified risk factor for pelvic actinomycosis: Actinomyces-like organisms colonize the cervix of IUD users, and colonization clears after the device is removed.
Show evidence (1 reference)
PMID:3526779 SUPPORT Human Clinical
"Among 815 intrauterine contraceptive device (IUD) users, the repeat smears from 57 women were positive for Actinomyces-like organisms, giving a prevalence rate of 6.99%."
Establishes IUD use as a documented risk context for Actinomyces colonization.
Mechanism Target:
PREDISPOSES Mucosal Barrier Breach and Endogenous Inoculation — A long-standing IUD provides a chronic nidus and a mucosal breach that lets commensal genital-tract Actinomyces colonize and invade pelvic tissue.
Show evidence (1 reference)
PMID:3526779 SUPPORT Human Clinical
"Among 815 intrauterine contraceptive device (IUD) users, the repeat smears from 57 women were positive for Actinomyces-like organisms, giving a prevalence rate of 6.99%."
Quantifies Actinomyces colonization in IUD users as a predisposing factor.
Dental focus of infection and poor oral hygiene
Odontogenic infection, dental procedures, and poor oral hygiene (with smoking) create the oral mucosal breaches that seed cervicofacial and aspiration-related pulmonary actinomycosis.
Show evidence (1 reference)
PMID:25045274 SUPPORT REVIEW SYNTHESIS Human Clinical
"cervicofacial actinomycosis following dental focus of infection, pelvic actinomycosis in women with an intrauterine device, and pulmonary actinomycosis in smokers with poor dental hygiene"
Establishes dental focus and poor oral hygiene as documented risk contexts.
Mechanism Target:
TRIGGERS Mucosal Barrier Breach and Endogenous Inoculation — A dental focus of infection disrupts the oral mucosal barrier and seeds commensal oral Actinomyces into deep cervicofacial tissue.
Show evidence (1 reference)
PMID:25045274 SUPPORT REVIEW SYNTHESIS Human Clinical
"cervicofacial actinomycosis following dental focus of infection, pelvic actinomycosis in women with an intrauterine device, and pulmonary actinomycosis in smokers with poor dental hygiene"
The review names dental focus and poor oral hygiene as the typical predisposing contexts.
🔬

Diagnosis

2
Histopathologic identification of sulfur granules
Tissue histopathology showing necrosis with characteristic yellow sulfur granules and radiating filamentous Gram-positive organisms establishes the diagnosis and distinguishes actinomycosis from malignancy.
Histopathologic examination for sulfur granules NCIT:C18190 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:25045274 SUPPORT REVIEW SYNTHESIS Human Clinical
"typical microscopic findings include necrosis with yellowish sulfur granules and filamentous Gram-positive fungal-like pathogens."
The review states that histopathology of sulfur granules is the characteristic diagnostic finding.
Prolonged anaerobic bacterial culture
Recovery of Actinomyces requires prolonged culture under anaerobic conditions; the fastidious, slow-growing organism is frequently missed on routine culture, contributing to diagnostic delay.
Anaerobic bacterial culture NCIT:C25300 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:25045274 SUPPORT REVIEW SYNTHESIS Human Clinical
"Prolonged bacterial cultures in anaerobic conditions are necessary to identify the bacterium"
The review states that prolonged anaerobic culture is necessary to recover Actinomyces.
📈

Progression

2
Indolent mass-forming infection
Actinomycosis progresses slowly over weeks to months and often reaches diagnosis only after a prolonged workup or surgery for suspected tumor or inflammatory bowel disease.
Show evidence (1 reference)
PMID:41712794 SUPPORT Human Clinical
"The mean time to diagnosis was 110 (30-540) days."
A 17-case series quantified a months-long diagnostic delay.
Central nervous system disease outcomes
CNS actinomycosis carries measurable mortality and lasting neurological morbidity even with treatment; a systematic review reported an overall case-fatality rate of 11% and neurological sequelae in 22% of survivors.
Show evidence (1 reference)
PMID:37269006 SUPPORT Human Clinical
"The overall case-fatality rate was 11%"
The 118-case CNS systematic review quantifies fatality.
🦠

Infectious Agent

1
Actinomyces
Anaerobic-to-microaerophilic Gram-positive bacteria that normally inhabit oral, gastrointestinal, and female genital mucosa and become invasive after barrier disruption; A. israelii is a classic human pathogen, but multiple Actinomyces and reclassified related species can cause disease.
Actinomyces NCBITaxon:1654 NCBI Taxonomy (NCBITaxon)
Show evidence (1 reference)
PMID:25045274 SUPPORT REVIEW SYNTHESIS Human Clinical
"Actinomycosis is a rare chronic disease caused by Actinomyces spp., anaerobic Gram-positive bacteria that normally colonize the human mouth and digestive and genital tracts."
Identifies Actinomyces species as the endogenous bacterial causes of actinomycosis.
↔️

Transmission

1
Endogenous infection after mucosal barrier disruption
Human actinomycosis is usually not acquired by person-to-person or animal transmission. Disease begins when commensal Actinomyces cross a disrupted oral, gastrointestinal, or genital mucosal barrier into deep tissue.
Show evidence (1 reference)
PMID:24905109 SUPPORT Human Clinical
"Actinomyces are considered to be residential saprophytes in the gastroinstetinal tract and require a mucosal lesion to cause an opportunistic infection."
Supports endogenous opportunistic infection after gastrointestinal mucosal injury.
{ }

Source YAML

click to show 
name: Actinomycosis
creation_date: '2026-09-25T00:00:00Z'
category: Infectious Disease
description: >-
  Actinomycosis is a rare, chronic, suppurative and granulomatous bacterial
  infection caused by endogenous Actinomyces species after disruption of the
  oral, gastrointestinal, or genital mucosal barrier. The anaerobic,
  filamentous Gram-positive organisms survive phagocytosis, form sulfur-granule
  lesions with necrosis and chronic inflammation, spread contiguously across
  tissue planes, form abscesses and sinus tracts, and often mimic malignancy in
  cervicofacial, pulmonary, abdominopelvic, or central nervous system sites.
  Prolonged high-dose beta-lactam therapy kills Actinomyces by inhibiting
  peptidoglycan cross-linking, and surgical resection or drainage is used for
  bulky, necrotic, or anatomically complicated disease.
disease_term:
  preferred_term: actinomycosis
  term:
    id: MONDO:0005631
    label: actinomycosis
references:
- reference: PMID:25045274
  title: "Actinomycosis: etiology, clinical features, diagnosis, treatment, and management."
  found_in:
  - Actinomycosis-deep-research-openscientist.md
  findings:
  - statement: >-
      Actinomycosis is an endogenous Actinomyces infection whose cervicofacial,
      pelvic, and pulmonary forms map to dental, IUD-associated, and pulmonary
      aspiration or poor-dental-hygiene contexts.
    supporting_text: >-
      Actinomycosis is a rare chronic disease caused by Actinomyces spp.,
      anaerobic Gram-positive bacteria that normally colonize the human mouth
      and digestive and genital tracts.
- reference: PMID:24905109
  title: "[Abdominal actinomycosis: a rare differential diagnosis to colon carcinoma and Morbus Crohn]."
  found_in:
  - Actinomycosis-deep-research-openscientist.md
  findings:
  - statement: >-
      Gastrointestinal Actinomyces require a mucosal lesion to cause
      opportunistic abdominal infection.
    supporting_text: >-
      Actinomyces are considered to be residential saprophytes in the
      gastroinstetinal tract and require a mucosal lesion to cause an
      opportunistic infection.
- reference: PMID:28684963
  title: "Pelvic Actinomycosis."
  found_in:
  - Actinomycosis-deep-research-openscientist.md
  findings:
  - statement: >-
      Pelvic actinomycosis is a chronic opportunistic Actinomyces infection
      associated with abscesses, fistulas, and altered mucosal barriers.
    supporting_text: >-
      Actinomycoses are opportunistic infections and require normal mucous
      barriers to be altered.
- reference: PMID:37269006
  title: "The epidemiology, clinical presentation and treatment outcomes in CNS actinomycosis: a systematic review of reported cases."
  found_in:
  - Actinomycosis-deep-research-openscientist.md
  findings:
  - statement: >-
      CNS actinomycosis is a rare severe form with brain abscesses, neurologic
      sequelae, and survival improved by surgery plus prolonged antimicrobials.
    supporting_text: >-
      CNS actinomycosis carries significant morbidity and mortality despite its
      indolent nature.
- reference: PMID:18976399
  title: "Mucocutaneous Splendore-Hoeppli phenomenon."
  found_in:
  - Actinomycosis-deep-research-openscientist.md
  findings:
  - statement: >-
      Actinomycosis can elicit Splendore-Hoeppli material, a localized
      antigen-antibody-rich inflammatory reaction around organisms.
    supporting_text: >-
      The bacterial infections include botryomycosis, nocardiosis and
      actinomycosis.
- reference: PMID:41712794
  title: "Actinomycosis: A diagnosis not to be forgotten."
  found_in:
  - Actinomycosis-deep-research-openscientist.md
  findings:
  - statement: >-
      A 17-case retrospective series documented a mean 110-day diagnostic delay
      and favorable outcome in 16 patients.
    supporting_text: "The mean time to diagnosis was 110 (30-540) days."
classifications:
  harrisons_chapter:
  - classification_value: INFECTIOUS_DISEASES
    evidence:
    - reference: PMID:25045274
      reference_title: "Actinomycosis: etiology, clinical features, diagnosis, treatment, and management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: >-
        Actinomycosis is a rare chronic disease caused by Actinomyces spp.,
        anaerobic Gram-positive bacteria that normally colonize the human mouth
        and digestive and genital tracts.
      explanation: >-
        The review defines actinomycosis as a bacterial disease caused by
        endogenous Actinomyces species, placing it in Harrison's Infectious
        Diseases Part.
parents:
- primary bacterial infectious disease
synonyms:
- actinomycotic infection
- lumpy jaw
has_subtypes:
- name: Cervicofacial
  display_name: Cervicofacial actinomycosis
  description: >-
    The classic dental-focus form, often arising after odontogenic infection or
    dental procedures and presenting as a mandibular, maxillary, or neck mass
    with possible sinus-tract drainage and mandibular osteomyelitis.
  subtype_term:
    preferred_term: cervicofacial actinomycosis
    term:
      id: MONDO:0005699
      label: cervicofacial actinomycosis
  evidence:
  - reference: PMID:25045274
    reference_title: "Actinomycosis: etiology, clinical features, diagnosis, treatment, and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "cervicofacial actinomycosis following dental focus of infection"
    explanation: The review identifies the cervicofacial form and its usual dental focus.
- name: Pulmonary
  display_name: Pulmonary or thoracic actinomycosis
  description: >-
    Thoracic infection linked to aspiration and poor dental hygiene; it can
    mimic lung cancer with mass-like or cavitary lesions and symptoms such as
    cough, dyspnea, fever, hemoptysis, malaise, and weight loss.
  evidence:
  - reference: PMID:25045274
    reference_title: "Actinomycosis: etiology, clinical features, diagnosis, treatment, and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "pulmonary actinomycosis in smokers with poor dental hygiene"
    explanation: The review identifies the pulmonary form and a characteristic dental-hygiene risk context.
- name: Abdominopelvic
  display_name: Abdominal and pelvic actinomycosis
  description: >-
    Infection of gastrointestinal or genital sites after a mucosal lesion or
    long-standing intrauterine device use; abdominal and pelvic cases can
    resemble inflammatory bowel disease or pelvic and colonic malignancy.
  evidence:
  - reference: PMID:24905109
    reference_title: "[Abdominal actinomycosis: a rare differential diagnosis to colon carcinoma and Morbus Crohn]."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The clinical presentation of abdominal actinomycosis shows a great
      variability and it often mimics other intraabdominal pathologies like
      chronic inflammatory bowel diseases or malignancies.
    explanation: The case report abstract characterizes the abdominal presentation and its malignancy/IBD mimicry.
  - reference: PMID:42287450
    reference_title: "Pelvic actinomycosis: diagnostic challenges and management strategies based on a retrospective case series and literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Pelvic actinomycosis is a rare, chronic infection caused by Actinomyces
      species, most associated with prolonged intrauterine device (IUD) use.
    explanation: The retrospective case series and literature review characterize the IUD-associated pelvic form.
- name: Central Nervous System
  display_name: Central nervous system actinomycosis
  description: >-
    A rare severe form of actinomycosis involving the brain, meninges, or spinal
    epidural space. A systematic review found brain abscess to be the most common
    neuroimaging finding and reported meaningful fatality and neurological
    sequelae rates.
  evidence:
  - reference: PMID:37269006
    reference_title: "The epidemiology, clinical presentation and treatment outcomes in CNS actinomycosis: a systematic review of reported cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Brain abscess (55%) followed by leptomeningeal enhancement (22%) were the most common neuroimaging findings."
    explanation: The 118-case systematic review defines brain abscess as the dominant CNS presentation.
infectious_agent:
- name: Actinomyces
  description: >-
    Anaerobic-to-microaerophilic Gram-positive bacteria that normally inhabit
    oral, gastrointestinal, and female genital mucosa and become invasive after
    barrier disruption; A. israelii is a classic human pathogen, but multiple
    Actinomyces and reclassified related species can cause disease.
  infectious_agent_term:
    preferred_term: Actinomyces
    term:
      id: NCBITaxon:1654
      label: Actinomyces
  evidence:
  - reference: PMID:25045274
    reference_title: "Actinomycosis: etiology, clinical features, diagnosis, treatment, and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      Actinomycosis is a rare chronic disease caused by Actinomyces spp.,
      anaerobic Gram-positive bacteria that normally colonize the human mouth
      and digestive and genital tracts.
    explanation: Identifies Actinomyces species as the endogenous bacterial causes of actinomycosis.
transmission:
- name: Endogenous infection after mucosal barrier disruption
  description: >-
    Human actinomycosis is usually not acquired by person-to-person or animal
    transmission. Disease begins when commensal Actinomyces cross a disrupted
    oral, gastrointestinal, or genital mucosal barrier into deep tissue.
  evidence:
  - reference: PMID:24905109
    reference_title: "[Abdominal actinomycosis: a rare differential diagnosis to colon carcinoma and Morbus Crohn]."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Actinomyces are considered to be residential saprophytes in the
      gastroinstetinal tract and require a mucosal lesion to cause an
      opportunistic infection.
    explanation: Supports endogenous opportunistic infection after gastrointestinal mucosal injury.
environmental:
- name: Long-standing intrauterine device use
  description: >-
    Prolonged intrauterine device (IUD) use is the best-quantified risk factor
    for pelvic actinomycosis: Actinomyces-like organisms colonize the cervix of
    IUD users, and colonization clears after the device is removed.
  influences_mechanisms:
  - target: Mucosal Barrier Breach and Endogenous Inoculation
    environmental_effect: PREDISPOSES
    causal_link_type: DIRECT
    description: >-
      A long-standing IUD provides a chronic nidus and a mucosal breach that lets
      commensal genital-tract Actinomyces colonize and invade pelvic tissue.
    evidence:
    - reference: PMID:3526779
      reference_title: "Actinomyces in cervical smears of women using intrauterine contraceptive devices."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Among 815 intrauterine contraceptive device (IUD) users, the repeat
        smears from 57 women were positive for Actinomyces-like organisms,
        giving a prevalence rate of 6.99%.
      explanation: Quantifies Actinomyces colonization in IUD users as a predisposing factor.
  evidence:
  - reference: PMID:3526779
    reference_title: "Actinomyces in cervical smears of women using intrauterine contraceptive devices."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Among 815 intrauterine contraceptive device (IUD) users, the repeat
      smears from 57 women were positive for Actinomyces-like organisms,
      giving a prevalence rate of 6.99%.
    explanation: Establishes IUD use as a documented risk context for Actinomyces colonization.
- name: Dental focus of infection and poor oral hygiene
  description: >-
    Odontogenic infection, dental procedures, and poor oral hygiene (with
    smoking) create the oral mucosal breaches that seed cervicofacial and
    aspiration-related pulmonary actinomycosis.
  influences_mechanisms:
  - target: Mucosal Barrier Breach and Endogenous Inoculation
    environmental_effect: TRIGGERS
    causal_link_type: DIRECT
    description: >-
      A dental focus of infection disrupts the oral mucosal barrier and seeds
      commensal oral Actinomyces into deep cervicofacial tissue.
    evidence:
    - reference: PMID:25045274
      reference_title: "Actinomycosis: etiology, clinical features, diagnosis, treatment, and management."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: >-
        cervicofacial actinomycosis following dental focus of infection, pelvic
        actinomycosis in women with an intrauterine device, and pulmonary
        actinomycosis in smokers with poor dental hygiene
      explanation: The review names dental focus and poor oral hygiene as the typical predisposing contexts.
  evidence:
  - reference: PMID:25045274
    reference_title: "Actinomycosis: etiology, clinical features, diagnosis, treatment, and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      cervicofacial actinomycosis following dental focus of infection, pelvic
      actinomycosis in women with an intrauterine device, and pulmonary
      actinomycosis in smokers with poor dental hygiene
    explanation: Establishes dental focus and poor oral hygiene as documented risk contexts.
progression:
- phase: Indolent mass-forming infection
  notes: >-
    Actinomycosis progresses slowly over weeks to months and often reaches
    diagnosis only after a prolonged workup or surgery for suspected tumor or
    inflammatory bowel disease.
  evidence:
  - reference: PMID:41712794
    reference_title: "Actinomycosis: A diagnosis not to be forgotten."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The mean time to diagnosis was 110 (30-540) days."
    explanation: A 17-case series quantified a months-long diagnostic delay.
- phase: Central nervous system disease outcomes
  notes: >-
    CNS actinomycosis carries measurable mortality and lasting neurological
    morbidity even with treatment; a systematic review reported an overall
    case-fatality rate of 11% and neurological sequelae in 22% of survivors.
  evidence:
  - reference: PMID:37269006
    reference_title: "The epidemiology, clinical presentation and treatment outcomes in CNS actinomycosis: a systematic review of reported cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The overall case-fatality rate was 11%"
    explanation: The 118-case CNS systematic review quantifies fatality.
diagnosis:
- name: Histopathologic identification of sulfur granules
  description: >-
    Tissue histopathology showing necrosis with characteristic yellow sulfur
    granules and radiating filamentous Gram-positive organisms establishes the
    diagnosis and distinguishes actinomycosis from malignancy.
  diagnosis_term:
    preferred_term: Histopathologic examination for sulfur granules
    term:
      id: NCIT:C18190
      label: Histopathologic Examination
  evidence:
  - reference: PMID:25045274
    reference_title: "Actinomycosis: etiology, clinical features, diagnosis, treatment, and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      typical microscopic findings include necrosis with yellowish sulfur
      granules and filamentous Gram-positive fungal-like pathogens.
    explanation: The review states that histopathology of sulfur granules is the characteristic diagnostic finding.
- name: Prolonged anaerobic bacterial culture
  description: >-
    Recovery of Actinomyces requires prolonged culture under anaerobic
    conditions; the fastidious, slow-growing organism is frequently missed on
    routine culture, contributing to diagnostic delay.
  diagnosis_term:
    preferred_term: Anaerobic bacterial culture
    term:
      id: NCIT:C25300
      label: Microbial Culture Procedure
  evidence:
  - reference: PMID:25045274
    reference_title: "Actinomycosis: etiology, clinical features, diagnosis, treatment, and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "Prolonged bacterial cultures in anaerobic conditions are necessary to identify the bacterium"
    explanation: The review states that prolonged anaerobic culture is necessary to recover Actinomyces.
pathophysiology:
- name: Mucosal Barrier Breach and Endogenous Inoculation
  description: >-
    Actinomyces species normally colonize oral, gastrointestinal, and genital
    mucosa. Dental foci, aspiration-prone poor oral hygiene, long-standing
    intrauterine devices, surgery, or trauma can disrupt the barrier and seed
    organisms into anaerobic deep tissue.
  role: trigger
  cell_types:
  - preferred_term: epithelial cell
    term:
      id: CL:0000066
      label: epithelial cell
  biological_processes:
  - preferred_term: response to bacterium
    term:
      id: GO:0009617
      label: response to bacterium
  evidence:
  - reference: PMID:25045274
    reference_title: "Actinomycosis: etiology, clinical features, diagnosis, treatment, and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      anaerobic Gram-positive bacteria that normally colonize the human mouth
      and digestive and genital tracts.
    explanation: Establishes that the pathogens are endogenous mucosal colonists.
  - reference: PMID:24905109
    reference_title: "[Abdominal actinomycosis: a rare differential diagnosis to colon carcinoma and Morbus Crohn]."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      require a mucosal lesion to cause an opportunistic infection.
    explanation: Establishes that a mucosal barrier lesion is needed for opportunistic invasion.
  downstream:
  - target: Intracellular Persistence in Phagocytes
    description: >-
      After inoculation into deep tissue, Actinomyces are phagocytosed but
      survive intracellularly, establishing a chronic focus.
    causal_link_type: DIRECT
- name: Intracellular Persistence in Phagocytes
  description: >-
    Although Actinomyces are phagocytosed by host cells, they are not killed and
    behave as facultative intracellular parasites. This failure of intracellular
    clearance is a proposed reason the infection becomes chronic rather than
    resolving.
  role: consequence
  cell_types:
  - preferred_term: macrophage
    term:
      id: CL:0000235
      label: macrophage
  evidence:
  - reference: PMID:2228706
    reference_title: "Cervicofacial actinomycosis in children."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: "The organism, although phagocytized by the host cells, is not killed."
    explanation: States that Actinomyces survive phagocytosis, the basis for chronic persistence.
  downstream:
  - target: Suppurative Granulomatous Sulfur-Granule Inflammation
    description: >-
      Persistent intracellular and deep-tissue organisms drive the chronic
      suppurative granulomatous response that forms sulfur granules.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
- name: Suppurative Granulomatous Sulfur-Granule Inflammation
  description: >-
    Deep-tissue Actinomyces infection produces necrosis with yellow sulfur
    granules containing filamentous Gram-positive organisms and a chronic
    granulomatous inflammatory reaction. Splendore-Hoeppli material can form
    around the bacteria as part of the localized antigen-antibody-rich response.
  role: consequence
  cell_types:
  - preferred_term: neutrophil
    term:
      id: CL:0000775
      label: neutrophil
  - preferred_term: macrophage
    term:
      id: CL:0000235
      label: macrophage
  biological_processes:
  - preferred_term: granuloma formation
    term:
      id: GO:0002432
      label: granuloma formation
  - preferred_term: inflammatory response
    term:
      id: GO:0006954
      label: inflammatory response
  evidence:
  - reference: PMID:25045274
    reference_title: "Actinomycosis: etiology, clinical features, diagnosis, treatment, and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      typical microscopic findings include necrosis with yellowish sulfur
      granules and filamentous Gram-positive fungal-like pathogens.
    explanation: Describes the characteristic necrotic sulfur-granule histopathology.
  - reference: PMID:18976399
    reference_title: "Mucocutaneous Splendore-Hoeppli phenomenon."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "The bacterial infections include botryomycosis, nocardiosis and actinomycosis."
    explanation: Identifies actinomycosis as a bacterial cause of the Splendore-Hoeppli phenomenon.
  downstream:
  - target: Abscess and Fistula Formation
    description: >-
      Chronic suppurative granulomatous inflammation coalesces into abscesses
      and fistulizing lesions.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
  - target: Fever
    description: The chronic inflammatory response produces systemic fever.
  - target: Weight loss
    description: Chronic infection produces constitutional weight loss.
  - target: Abdominal pain
    description: >-
      Suppurative inflammation of gastrointestinal-site actinomycosis produces
      abdominal pain.
- name: Abscess and Fistula Formation
  description: >-
    The persistent inflammatory focus organizes into abscesses and fistulas that
    can drain to skin or mucosal surfaces through sinus tracts.
  role: consequence
  biological_processes:
  - preferred_term: inflammatory response
    term:
      id: GO:0006954
      label: inflammatory response
  evidence:
  - reference: PMID:28684963
    reference_title: "Pelvic Actinomycosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      Its symptomatology imitates some malignant pelvic tumours, tuberculosis,
      or nocardiosis, causing abscesses and fistulas.
    explanation: The pelvic review reports abscess and fistula formation in actinomycosis.
  downstream:
  - target: Contiguous Spread Across Tissue Planes
    description: >-
      Abscesses and fistulas extend across normal anatomic barriers rather than
      respecting them.
    causal_link_type: DIRECT
  - target: Abscess
    description: Suppurative lesions present clinically as abscesses.
  - target: Draining Sinus Tract
    description: Contiguous suppuration drains through sinus tracts.
  - target: Brain Abscess
    description: In the CNS form, abscess formation presents as brain abscess.
- name: Contiguous Spread Across Tissue Planes
  description: >-
    Actinomycosis characteristically extends contiguously across fascial and
    anatomic planes, invading adjacent bone, pleura, and soft tissue rather than
    metastasizing.
  role: consequence
  biological_processes:
  - preferred_term: inflammatory response
    term:
      id: GO:0006954
      label: inflammatory response
  evidence:
  - reference: PMID:25045274
    reference_title: "Actinomycosis: etiology, clinical features, diagnosis, treatment, and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "Cervicofacial actinomycosis could be associated with large abscesses and/or mandibular osteomyelitis with or without sinus tract"
    explanation: Documents contiguous extension of cervicofacial disease into mandibular bone.
  downstream:
  - target: Mass Mimicking Malignancy
    description: >-
      Contiguous infiltration forms an indurated mass that clinically and
      radiologically resembles a tumor.
    causal_link_type: DIRECT
  - target: Reactive Fibrosis
    description: Chronic infiltration provokes reactive fibrosis in involved tissue.
  - target: Osteomyelitis
    description: Contiguous spread into adjacent bone produces osteomyelitis.
  - target: Pleural effusion
    description: >-
      Thoracic contiguous spread to the pleura produces pleural involvement and
      effusion.
- name: Mass Mimicking Malignancy
  description: >-
    The infiltrative inflammatory mass mimics malignancy at cervicofacial,
    pulmonary, abdominal, pelvic, and CNS sites, and is the reason actinomycosis
    is commonly mistaken for a tumor before tissue diagnosis. No suitably
    specific cross-site HP term exists for an infection-related infiltrative
    mass, so the mass is modeled as a mechanism node with site-specific mass and
    airway phenotypes bound below.
  role: consequence
  biological_processes:
  - preferred_term: inflammatory response
    term:
      id: GO:0006954
      label: inflammatory response
  evidence:
  - reference: PMID:42717451
    reference_title: "Postoperative abdominal wall actinomycosis mimicking malignancy: a case report and literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Actinomycosis is an uncommon chronic bacterial infection that may present as an infiltrative mass mimicking malignancy."
    explanation: States that actinomycosis presents as an infiltrative mass mimicking malignancy.
  - reference: PMID:25045274
    reference_title: "Actinomycosis: etiology, clinical features, diagnosis, treatment, and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "actinomycosis may mimic the malignancy process in various anatomical sites."
    explanation: General review support for malignancy mimicry across sites.
  downstream:
  - target: Abdominal mass
    description: >-
      The infiltrative mass presents as a palpable abdominal mass in
      gastrointestinal-site disease.
  - target: Cough
    description: A pulmonary mass-forming lesion produces cough.
  - target: Dyspnea
    description: Pulmonary mass and consolidation produce dyspnea.
  - target: Hemoptysis
    description: Airway and parenchymal involvement produces hemoptysis.
- name: Reactive Fibrosis
  description: >-
    Chronic actinomycotic inflammation drives reactive fibrosis, producing the
    dense fibrotic lesions that can require excision.
  role: consequence
  cell_types:
  - preferred_term: fibroblast
    term:
      id: CL:0000057
      label: fibroblast
  evidence:
  - reference: PMID:42717451
    reference_title: "Postoperative abdominal wall actinomycosis mimicking malignancy: a case report and literature review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "associated with granulation tissue and reactive fibrosis"
    explanation: Histopathology of an actinomycosis mass reports reactive fibrosis.
- name: Actinomyces Peptidoglycan Cross-Linking (Beta-Lactam Target)
  description: >-
    Actinomyces are bacteria with peptidoglycan cell walls. Penicillin and
    amoxicillin inhibit the penicillin-binding protein DD-transpeptidases that
    cross-link peptidoglycan, leaving growing organisms unable to maintain the
    load-bearing sacculus.
  role: therapeutic_vulnerability
  conforms_to: "bacterial_cell_wall_synthesis_inhibition#Peptidoglycan Cross-Linking by Penicillin-Binding Proteins"
  biological_processes:
  - preferred_term: peptidoglycan-based cell wall biogenesis
    term:
      id: GO:0009273
      label: peptidoglycan-based cell wall biogenesis
  evidence:
  - reference: PMID:22203377
    reference_title: "From the regulation of peptidoglycan synthesis to bacterial growth and morphology."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Peptidoglycan synthesis requires glycosyltransferases (GTases) to
      polymerize the glycan chains and DD-transpeptidases (DD-TPases) to
      crosslink the peptides
    explanation: >-
      Establishes the conserved bacterial peptidoglycan cross-linking step that
      beta-lactams inhibit.
  - reference: PMID:25045274
    reference_title: "Actinomycosis: etiology, clinical features, diagnosis, treatment, and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "penicillin G or amoxicillin are considered drugs of choice for the treatment of actinomycosis."
    explanation: >-
      The Actinomyces-specific review establishes that penicillin G or
      amoxicillin, which act on this peptidoglycan cross-linking step, are the
      drugs of choice.
phenotypes:
- name: Abscess
  description: >-
    Suppurative actinomycosis forms abscesses, especially in pelvic, CNS, and
    other deep-tissue forms.
  phenotype_term:
    preferred_term: Abscess
    term:
      id: HP:0025615
      label: Abscess
  evidence:
  - reference: PMID:28684963
    reference_title: "Pelvic Actinomycosis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      Its symptomatology imitates some malignant pelvic tumours, tuberculosis,
      or nocardiosis, causing abscesses and fistulas.
    explanation: The pelvic systematic review describes abscess and fistula formation as part of actinomycosis.
- name: Draining Sinus Tract
  description: >
    Cervicofacial and cutaneous extension can drain through sinus tracts.
  phenotype_term:
    preferred_term: Draining sinus tract in skin
    term:
      id: HP:6000095
      label: Draining sinus tract in skin
  evidence:
  - reference: PMID:25045274
    reference_title: "Actinomycosis: etiology, clinical features, diagnosis, treatment, and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "multiple abscesses with draining sinus tracts on the skin surface or oral mucosa"
    explanation: The review directly states that draining sinus tracts form on skin or oral mucosa.
- name: Fever
  description: Fever occurs among the nonspecific systemic manifestations, particularly in thoracic presentations.
  phenotype_term:
    preferred_term: Fever
    term:
      id: HP:0001945
      label: Fever
  evidence:
  - reference: PMID:42007821
    reference_title: "Pulmonary actinomycosis and pulmonary nocardiosis mimicking lung cancer: A case series and narrative review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      patients commonly presented with cough, dyspnea, fever, hemoptysis,
      malaise, and weight loss.
    explanation: The pulmonary case series and review lists fever among common presenting symptoms.
- name: Cough
  description: Cough is a common pulmonary actinomycosis symptom.
  subtype: Pulmonary
  phenotype_term:
    preferred_term: Cough
    term:
      id: HP:0012735
      label: Cough
  evidence:
  - reference: PMID:42007821
    reference_title: "Pulmonary actinomycosis and pulmonary nocardiosis mimicking lung cancer: A case series and narrative review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      patients commonly presented with cough, dyspnea, fever, hemoptysis,
      malaise, and weight loss.
    explanation: The pulmonary case series and review lists cough among common presenting symptoms.
- name: Dyspnea
  description: Dyspnea occurs with pulmonary mass and consolidation.
  subtype: Pulmonary
  phenotype_term:
    preferred_term: Dyspnea
    term:
      id: HP:0002094
      label: Dyspnea
  evidence:
  - reference: PMID:42007821
    reference_title: "Pulmonary actinomycosis and pulmonary nocardiosis mimicking lung cancer: A case series and narrative review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      patients commonly presented with cough, dyspnea, fever, hemoptysis,
      malaise, and weight loss.
    explanation: The pulmonary case series and review lists dyspnea among common presenting symptoms.
- name: Hemoptysis
  description: Hemoptysis occurs with airway and parenchymal pulmonary involvement.
  subtype: Pulmonary
  phenotype_term:
    preferred_term: Hemoptysis
    term:
      id: HP:0002105
      label: Hemoptysis
  evidence:
  - reference: PMID:42007821
    reference_title: "Pulmonary actinomycosis and pulmonary nocardiosis mimicking lung cancer: A case series and narrative review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      patients commonly presented with cough, dyspnea, fever, hemoptysis,
      malaise, and weight loss.
    explanation: The pulmonary case series and review lists hemoptysis among common presenting symptoms.
- name: Weight loss
  description: Constitutional weight loss occurs in chronic actinomycosis.
  phenotype_term:
    preferred_term: Weight loss
    term:
      id: HP:0001824
      label: Weight loss
  evidence:
  - reference: PMID:42007821
    reference_title: "Pulmonary actinomycosis and pulmonary nocardiosis mimicking lung cancer: A case series and narrative review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      patients commonly presented with cough, dyspnea, fever, hemoptysis,
      malaise, and weight loss.
    explanation: The pulmonary case series and review lists weight loss among common presenting symptoms.
- name: Pleural effusion
  description: Thoracic actinomycosis frequently involves the pleura.
  subtype: Pulmonary
  phenotype_term:
    preferred_term: Pleural effusion
    term:
      id: HP:0002202
      label: Pleural effusion
  evidence:
  - reference: PMID:25045274
    reference_title: "Actinomycosis: etiology, clinical features, diagnosis, treatment, and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "Pleural involvement, with thickening, effusion, or empyema"
    explanation: The review documents pleural involvement including effusion in thoracic actinomycosis.
- name: Osteomyelitis
  description: Contiguous spread into adjacent bone produces osteomyelitis, classically mandibular.
  subtype: Cervicofacial
  phenotype_term:
    preferred_term: Osteomyelitis
    term:
      id: HP:0002754
      label: Osteomyelitis
  evidence:
  - reference: PMID:25045274
    reference_title: "Actinomycosis: etiology, clinical features, diagnosis, treatment, and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "Cervicofacial actinomycosis could be associated with large abscesses and/or mandibular osteomyelitis with or without sinus tract"
    explanation: The review documents mandibular osteomyelitis in cervicofacial actinomycosis.
- name: Abdominal pain
  description: Abdominal pain is a common presentation of gastrointestinal-site actinomycosis.
  subtype: Abdominopelvic
  phenotype_term:
    preferred_term: Abdominal pain
    term:
      id: HP:0002027
      label: Abdominal pain
  evidence:
  - reference: PMID:25045274
    reference_title: "Actinomycosis: etiology, clinical features, diagnosis, treatment, and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "patients with appendix, cecum, or colon actinomycosis frequently have abdominal pain with a palpable mass"
    explanation: The review reports abdominal pain with a palpable mass in gastrointestinal actinomycosis.
- name: Abdominal mass
  description: Gastrointestinal-site actinomycosis frequently presents as a palpable abdominal mass mimicking a tumor.
  subtype: Abdominopelvic
  phenotype_term:
    preferred_term: Abdominal mass
    term:
      id: HP:0031500
      label: Abdominal mass
  evidence:
  - reference: PMID:25045274
    reference_title: "Actinomycosis: etiology, clinical features, diagnosis, treatment, and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: "patients with appendix, cecum, or colon actinomycosis frequently have abdominal pain with a palpable mass"
    explanation: The review reports a palpable abdominal mass in gastrointestinal actinomycosis.
- name: Brain Abscess
  description: Brain abscess is the most common neuroimaging finding in CNS actinomycosis.
  subtype: Central Nervous System
  phenotype_term:
    preferred_term: Brain abscess
    term:
      id: HP:0030049
      label: Brain abscess
  evidence:
  - reference: PMID:37269006
    reference_title: "The epidemiology, clinical presentation and treatment outcomes in CNS actinomycosis: a systematic review of reported cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Brain abscess (55%) followed by leptomeningeal enhancement (22%) were the most common neuroimaging findings."
    explanation: The systematic review of 118 CNS cases quantifies brain abscess frequency.
treatments:
- name: Prolonged Penicillin or Amoxicillin Therapy
  description: >-
    Prolonged high-dose beta-lactam treatment with intravenous penicillin G or
    oral amoxicillin is the standard Actinomyces-directed antimicrobial
    strategy; courses usually last 6-12 months and may be shortened after
    complete surgical resection of infected tissue.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: benzylpenicillin
      term:
        id: CHEBI:18208
        label: benzylpenicillin
    - preferred_term: amoxicillin
      term:
        id: CHEBI:2676
        label: amoxicillin
  therapeutic_modality: SMALL_MOLECULE
  target_mechanisms:
  - target: Actinomyces Peptidoglycan Cross-Linking (Beta-Lactam Target)
    description: >-
      Penicillin G and amoxicillin acylate bacterial penicillin-binding proteins
      and block peptidoglycan cross-linking in susceptible Actinomyces.
  evidence:
  - reference: PMID:25045274
    reference_title: "Actinomycosis: etiology, clinical features, diagnosis, treatment, and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      Patients with actinomycosis require prolonged (6- to 12-month) high doses
      (to facilitate the drug penetration in abscess and in infected tissues) of
      penicillin G or amoxicillin
    explanation: Review support for prolonged high-dose penicillin G or amoxicillin therapy.
- name: Surgical Resection or Drainage
  description: >-
    Surgery drains abscesses, removes necrotic or fibrotic infected tissue, and
    establishes a histologic diagnosis when actinomycosis mimics cancer; in CNS
    disease, surgery combined with antimicrobials is associated with better
    survival than antimicrobials alone.
  therapeutic_modality: SURGERY
  target_mechanisms:
  - target: Reactive Fibrosis
    description: Surgery excises bulky fibrotic or necrotic infected tissue.
  - target: Abscess and Fistula Formation
    description: Surgery drains abscesses and marsupializes chronic sinus tracts.
  treatment_term:
    preferred_term: Surgical Procedure
    term:
      id: NCIT:C15329
      label: Surgical Procedure
  evidence:
  - reference: PMID:25045274
    reference_title: "Actinomycosis: etiology, clinical features, diagnosis, treatment, and management."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: >-
      the duration of antimicrobial therapy could probably be shortened to 3
      months in patients in whom optimal surgical resection of infected tissues
      has been performed.
    explanation: The review describes surgical resection as a way to reduce infected tissue burden and shorten antimicrobial therapy.
  - reference: PMID:37269006
    reference_title: "The epidemiology, clinical presentation and treatment outcomes in CNS actinomycosis: a systematic review of reported cases."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      patients who underwent surgery with antimicrobials had better survival
      (adjusted OR 0.14, 95% CI 0.04-0.28, p value 0.039) compared to those
      treated with antimicrobials alone.
    explanation: The CNS systematic review reports improved survival with combined surgery and antimicrobials.
- name: Intrauterine device removal
  description: >-
    In IUD-associated pelvic actinomycosis, removing the device eliminates the
    nidus of Actinomyces colonization; colonization clears after removal even
    without antibiotics.
  target_mechanisms:
  - target: Mucosal Barrier Breach and Endogenous Inoculation
    description: >-
      Removing the intrauterine device eliminates the chronic device-associated
      nidus that seeds pelvic Actinomyces colonization and invasion.
  evidence:
  - reference: PMID:6529911
    reference_title: "Influence of removal of intrauterine contraceptive devices on colonisation of the cervix by actinomyces-like organisms."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      After removal of the IUCD, and without antibiotic therapy, in 100%
      (20/20) of the women, ALO colonisation was no longer found six to twelve
      months later.
    explanation: Colonization cleared in all women after IUD removal, supporting removal as management.
notes: >-
  MONDO provides a specific term for cervicofacial actinomycosis
  (MONDO:0005699), but a search of MONDO via OLS (runoak -i ols:mondo search
  "l~actinomycosis") on 2026-09-26 returned only MONDO:0005631 (actinomycosis),
  MONDO:0005699 (cervicofacial actinomycosis), and MONDO:1013487 (actinomycosis,
  non-human animal) - no thoracic, pulmonary, abdominal, pelvic, or CNS
  actinomycosis subtype terms exist. Those anatomical forms are therefore
  represented as ungrounded subtypes until suitable MONDO classes exist. The
  cross-site "infiltrative mass mimicking malignancy" hallmark is modeled as the
  "Mass Mimicking Malignancy" pathophysiology node because no HP term for an
  infection-related infiltrative soft-tissue mass exists across sites; the
  concrete Abdominal mass phenotype (HP:0031500) grounds the gastrointestinal
  presentation.
📚

References & Deep Research

References

6
PMID:25045274
Actinomycosis: etiology, clinical features, diagnosis, treatment, and management.
1 finding
Actinomycosis is an endogenous Actinomyces infection whose cervicofacial, pelvic, and pulmonary forms map to dental, IUD-associated, and pulmonary aspiration or poor-dental-hygiene contexts.
"Actinomycosis is a rare chronic disease caused by Actinomyces spp., anaerobic Gram-positive bacteria that normally colonize the human mouth and digestive and genital tracts."
PMID:24905109
[Abdominal actinomycosis: a rare differential diagnosis to colon carcinoma and Morbus Crohn].
1 finding
Gastrointestinal Actinomyces require a mucosal lesion to cause opportunistic abdominal infection.
"Actinomyces are considered to be residential saprophytes in the gastroinstetinal tract and require a mucosal lesion to cause an opportunistic infection."
PMID:28684963
Pelvic Actinomycosis.
1 finding
Pelvic actinomycosis is a chronic opportunistic Actinomyces infection associated with abscesses, fistulas, and altered mucosal barriers.
"Actinomycoses are opportunistic infections and require normal mucous barriers to be altered."
PMID:37269006
The epidemiology, clinical presentation and treatment outcomes in CNS actinomycosis: a systematic review of reported cases.
1 finding
CNS actinomycosis is a rare severe form with brain abscesses, neurologic sequelae, and survival improved by surgery plus prolonged antimicrobials.
"CNS actinomycosis carries significant morbidity and mortality despite its indolent nature."
PMID:18976399
Mucocutaneous Splendore-Hoeppli phenomenon.
1 finding
Actinomycosis can elicit Splendore-Hoeppli material, a localized antigen-antibody-rich inflammatory reaction around organisms.
"The bacterial infections include botryomycosis, nocardiosis and actinomycosis."
PMID:41712794
Actinomycosis: A diagnosis not to be forgotten.
1 finding
A 17-case retrospective series documented a mean 110-day diagnostic delay and favorable outcome in 16 patients.
"The mean time to diagnosis was 110 (30-540) days."

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (1)

Create: Actinomycosis · 2026-09-25T04:21:14Z · View source

Created a de novo Actinomycosis entry from OpenScientist deep research, with an Actinomyces infectious-agent binding, endogenous mucosal-barrier transmission, four anatomical subtype records, a compact suppurative-granulomatous causal chain, five cited phenotype manifestations, beta-lactam and surgical treatment records, and generated PubMed reference caches.

OpenScientist ▸
Key Findings
openscientist-autonomous 31 citations 2026-09-24T21:05:26.933960

Key Findings

F001 — Actinomycosis is caused by commensal Actinomyces that turn invasive only after a mucosal breach

Actinomycosis is defined by a two-part causal logic: an organism that is normally harmless, plus a triggering event that lets it into tissue where it does not belong. The comprehensive review by Valour et al. establishes that Actinomyces spp. are anaerobic Gram-positive bacteria that normally colonize the human mouth, digestive tract, and genital tract — "Actinomycosis is a rare chronic disease caused by Actinomyces spp., anaerobic Gram-positive bacteria that normally colonize the human mouth and digestive and genital tracts" (PMID: 25045274). Because the organism is a commensal, disease is fundamentally opportunistic: it requires disruption of the mucosal barrier. The abdominal actinomycosis review makes this explicit — "Actinomyces are considered to be residential saprophytes in the gastrointestinal tract and require a mucosal lesion to cause an opportunistic infection" (PMID: 24905109). This is the initiating step of the entire pathogenic cascade and explains why the disease has no genetic etiology and why prevention hinges on protecting mucosal integrity.

F002 — Three classic clinical forms map to distinct predisposing factors; the disease mimics malignancy

The disease presents in anatomically distinct but mechanistically unified forms. Valour et al. describe "cervicofacial actinomycosis following dental focus of infection, pelvic actinomycosis in women with an intrauterine device, and pulmonary actinomycosis in smokers with poor dental hygiene" (PMID: 25045274). Each form corresponds to a specific mode of mucosal breach: odontogenic infection (cervicofacial), IUD-associated genital colonization (pelvic — "Pelvic actinomycosis is a rare, chronic infection caused by Actinomyces species, most associated with prolonged intrauterine device (IUD) use," PMID: 42287450), and aspiration with poor dental hygiene (pulmonary). A defining and clinically dangerous feature across all sites is tumor mimicry: independent case series report infiltrative mass lesions raising suspicion for cancer in the lung (PMID: 42007821), liver (PMID: 42501997), pelvis (PMID: 42287450), mandible (PMID: 41871568), and abdominal wall (PMID: 42717451). This mimicry frequently drives patients to major, sometimes unnecessary, surgery.

F003 — Diagnosis rests on sulfur granules and prolonged anaerobic culture; often only after surgery

Diagnosis is notoriously difficult. Valour et al. note that "Prolonged bacterial cultures in anaerobic conditions are necessary to identify the bacterium and typical microscopic findings include necrosis with yellowish sulfur granules and filamentous Gram-positive fungal-like pathogens" (PMID: 25045274). Culture, though the microbiological gold standard, has high false-negative rates, so the diagnosis is more often histopathological (PMID: 24905109). A retrospective series of 17 patients quantified the diagnostic delay: "The mean time to diagnosis was 110 (30–540) days," with diagnosis made pathologically in 13/17 versus microbiologically in 4/17 (PMID: 41712794). Modern molecular methods — 16S rRNA gene sequencing and metagenomic next-generation sequencing (mNGS) — are increasingly decisive, as seen in a cardiac case confirmed by 16S rRNA (PMID: 38077408) and multiple osteomyelitis cases identified only by mNGS (PMID: 42604646, PMID: 41691170).

F004 — Prolonged high-dose penicillin/amoxicillin cures actinomycosis with excellent prognosis

Treatment is a long course of beta-lactam antibiotics. Valour et al.: "Patients with actinomycosis require prolonged (6- to 12-month) high doses ... of penicillin G or amoxicillin, but the duration of antimicrobial therapy could probably be shortened to 3 months in patients in whom optimal surgical resection of infected tissues has been performed" (PMID: 25045274). Outcomes are excellent. In a series of 17, "the outcome was favorable in 16 cases" (94%) (PMID: 41712794). In 7 renal transplant recipients, all treated with amoxicillin for a median of 115 days (range 30–200), "all patients, except one, recovered completely" (PMID: 30055044). Resistance rates are low, and IV-then-oral penicillin for ≥4 weeks is advisable (PMID: 24905109).

F005 — Actinomyces evades intracellular killing and elicits a Splendore–Hoeppli granulomatous reaction

The chronicity of actinomycosis is explained by immune evasion. Friduss & Maceri report that "The organism, although phagocytized by the host cells, is not killed. Therefore, it is defined as a facultative intracellular parasite of the host" (PMID: 2228706). The host response produces the disease's signature histology, the Splendore–Hoeppli phenomenon: "The Splendore-Hoeppli reaction material comprises antigen-antibody complex, tissue debris and fibrin" and represents a localized immunological response to which actinomycosis is a recognized bacterial cause (PMID: 18976399). A cardiac actinomycosis biopsy demonstrated abscess formation with the Splendore–Hoeppli phenomenon and Gram-positive/Grocott-positive filaments, confirmed by 16S rRNA sequencing (PMID: 38077408).

F006 — Actinomycosis is a comparative disease of cattle and wild cervids

While not classically zoonotic (person-to-person or animal-to-person transmission is not a feature), naturally occurring Actinomyces disease is well documented in animals. Friduss & Maceri note "Actinomycotic infections, once common in humans and cattle, are now rare causes of disease in man" (PMID: 2228706) — the bovine form is classic "lumpy jaw." In wild cervids, granulomatous lymphadenitis showed Splendore–Hoeppli material in 93% of cases, with "Organisms morphologically consistent with Actinomyces spp. ... found in one white-tailed deer," and focal granulomatous lymphadenitis occurring in 0.3–1.3% of deer (PMID: 19617472).

F007 — IUD use promotes genital Actinomyces colonization in a device- and duration-dependent, reversible manner

The IUD–Actinomyces relationship is one of the best-quantified in the field. Mali et al. found that among 815 IUD users, "the repeat smears from 57 women were positive for Actinomyces-like organisms, giving a prevalence rate of 6.99%" (with A. israelii confirmed by immunofluorescence in all and cultured in 23/40), while all non-users were negative; prolonged use (>2 years) promoted overgrowth (PMID: 3526779). Device type matters: Mao & Guillebaud reported actinomyces-like organism (ALO) prevalence of 22.6% with inert versus 2% with copper IUDs, and — critically — "After removal of the IUCD, and without antibiotic therapy, in 100% (20/20) of the women, ALO colonisation was no longer found six to twelve months later" (PMID: 6529911). A systematic review of pelvic actinomycosis (63 articles, 1980–2014) confirmed the dominant IUD association and the typical route of diagnosis by histology after surgery (PMID: 28684963). This finding establishes both a dose–response (duration, device type) and reversibility — an unusually clean exposure–response relationship for an infectious disease.

F008 — CNS actinomycosis carries ~11% mortality; combined surgery + antibiotics improves survival

CNS disease is the principal exception to the disease's generally benign prognosis. A systematic review of 118 CNS actinomycosis cases (1988–2022) found a mean age of 44 years, 57% male; A. israelii most common (41.5%) followed by A. meyeri (22.6%); brain abscess in 55%, leptomeningeal enhancement in 22%, culture positivity 53.4%, and disseminated disease in 19.5%. Outcomes were markedly worse than localized disease: "The overall case-fatality rate was 11%. Neurological sequelae were present in 22% of the patients" (PMID: 37269006). Multivariate analysis showed a survival benefit of combined management — "patients who underwent surgery with antimicrobials had better survival (adjusted OR 0.14, 95% CI 0.04–0.28)" (PMID: 37269006). This contrasts with the ~94% favorable outcome for localized disease (PMID: 41712794).

F009 — Pathogenesis is driven by fimbrial/pilus adhesins, coaggregation, and polymicrobial biofilm formation

The sulfur granule is not a pure culture but a polymicrobial biofilm built by molecular adhesion mechanisms. Cisar describes how indigenous Gram-positive tooth colonizers "including viridans streptococci and actinomyces" evade host secretory inhibitors of adhesion through the structural design and binding properties of bacterial adhesins/receptors (PMID: 9524453). Kumari Yadav et al. show that "Early colonization by S. oralis and its interaction with Actinomyces oris seeds the development of oral biofilm or dental plaque," mediated by sortase-dependent pili (PMID: 31929180). Companion organisms enable deep-tissue invasion: "Periodontal pathogens or their pathogenic products must be able to pass through the epithelial cell barrier in order to reach and cause destruction to underlying tissues" (PMID: 10522226). This explains why actinomycosis is fundamentally a synergistic polymicrobial infection.

Section-by-Section Report

1. Disease Information

Overview. Actinomycosis is a rare chronic granulomatous and suppurative bacterial infection caused by Actinomyces species, anaerobic-to-microaerophilic Gram-positive filamentous bacteria that are normal commensals of the human oropharynx, gastrointestinal tract, and female genital tract. It is characterized by indolent progression, formation of abscesses and draining sinus tracts, extension across normal tissue planes (disregarding anatomical boundaries), dense fibrosis, and the pathognomonic "sulfur granules." It classically mimics malignancy.

Key identifiers: - MONDO: MONDO:0001580 (actinomycosis) - ICD-10: A42 (A42.0 pulmonary, A42.1 abdominal, A42.2 cervicofacial, A42.7 actinomycotic sepsis, A42.8 other, A42.9 unspecified) - ICD-11: 1C10 (Actinomycosis) - MeSH: D000196 (Actinomycosis) - OMIM / Orphanet: Not a Mendelian disorder; no OMIM entry. Not a heritable rare disease (acquired infection). - SNOMED CT: 63455001 (Actinomycosis)

Synonyms / alternative names: "Lumpy jaw" (cervicofacial and bovine forms), actinomycotic infection, "the most misdiagnosed disease." Historically confused with fungal disease owing to filamentous morphology (hence "fungal-like").

Information source type: Aggregated disease-level knowledge derived from case reports, retrospective case series, and systematic reviews (e.g., PMID: 25045274, PMID: 28684963, PMID: 37269006). There is no large EHR-derived individual-patient dataset; the disease's rarity means the evidence base is dominated by pooled case-level literature.

2. Etiology

Primary cause — infectious. The disease is caused by Actinomyces spp. (commensal anaerobic Gram-positive bacteria) that become invasive after a mucosal breach (PMID: 25045274; PMID: 24905109). It is not a genetic disease — there are no causal genes, no Mendelian inheritance, and no established susceptibility loci. Infection is typically polymicrobial, with companion bacteria (e.g., Aggregatibacter actinomycetemcomitans, Streptococcus spp., Finegoldia magna, Staphylococcus spp., Enterobacteriaceae, Fusobacterium) contributing to invasion and biofilm architecture (PMID: 31929180; PMID: 10522226; PMID: 41691170).

Risk factors (environmental/host): - Genetic: None established. Immunosuppression is facilitating, not required (most cases occur in immunocompetent hosts). - Dental disease and dental procedures → cervicofacial disease (PMID: 25045274). - Long-standing IUD (especially inert/plastic, >2 years) → pelvic/abdominal disease (PMID: 3526779; PMID: 6529911; PMID: 28684963). - Smoking + poor oral hygiene, aspiration → pulmonary/thoracic disease (PMID: 25045274). - Trauma / surgery (post-surgical abdominal wall, post-traumatic osteomyelitis) → localized soft-tissue and bone disease (PMID: 42717451; PMID: 41691170; PMID: 42604646). - Immunosuppression (e.g., renal transplant, though prevalence very low at 0.02%) (PMID: 30055044); poor socioeconomic status noted in a CNS case (PMID: 30572823).

Protective factors: Good dental hygiene; copper rather than inert IUDs (ALO prevalence 2% vs 22.6%, PMID: 6529911); timely IUD removal/exchange (clears colonization in 100% within 6–12 months without antibiotics, PMID: 6529911). One historical report speculated that cyclical menstrual flow may act as a protective "cleansing mechanism" (PMID: 6481117). No genetic protective factors are known.

Gene–environment interactions: Not applicable in the classical sense — actinomycosis has no genetic component. The relevant interaction is host-barrier × microbial-colonization: the same commensal is harmless on an intact mucosa and pathogenic once the barrier is breached.

3. Phenotypes

Phenotypes are anatomically driven. Common features across forms:

Phenotype Type Frequency / notes Suggested HPO
Chronic infiltrative mass mimicking tumor Clinical sign Hallmark across sites (PMID: 42007821, PMID: 42501997) HP:0002664 (Neoplasm — mimic)
Draining sinus tracts / fistulae Physical manifestation Classic in cervicofacial and abdominal (PMID: 6481117) HP:0100279 (Fistula)
Sulfur granules in discharge/tissue Lab/pathology Pathognomonic when present —
Fever, night sweats Symptom Common, nonspecific (PMID: 38077408) HP:0001945 (Fever)
Weight loss Symptom Common (PMID: 42501997, PMID: 20458215) HP:0001824 (Weight loss)
Cough, dyspnea, hemoptysis, chest pain Symptom Pulmonary form (PMID: 42007821) HP:0012735, HP:0002094, HP:0002105
Trismus, neck/jaw swelling Clinical sign Cervicofacial (PMID: 41871568) HP:0000211 (Trismus)
Osteomyelitis (mandible, phalanx, fibula) Physical manifestation Bone involvement (PMID: 41871568, PMID: 41691170, PMID: 42604646) HP:0002754 (Osteomyelitis)
Abdominal/pelvic mass, pain Symptom/sign Abdominopelvic form (PMID: 42287450) HP:0004396, HP:0002027
Pericardial effusion / constriction Clinical sign Rare thoracic/cardiac (PMID: 38077408) HP:0001698 (Pericardial effusion)
Elevated inflammatory markers Lab abnormality Variable (PMID: 41871568) HP:0011897 (Neutrophilia)

Characteristics: Onset is typically adult (mean ~44 y in CNS series). Course is chronic, indolent, progressive if untreated, punctuated by episodic abscess/sinus formation. Severity is variable — from an indolent local mass to fatal disseminated/CNS disease. Quality of life is impaired mainly by diagnostic delay, disfiguring surgery, and prolonged antibiotic courses; CNS disease leaves neurological sequelae in ~22% (PMID: 37269006).

4. Genetic / Molecular Information

Not applicable to the human host. Actinomycosis has no causal human genes, no pathogenic germline/somatic variants, no modifier genes, no chromosomal abnormalities, and no established disease-associated epigenetic changes. It is an acquired bacterial infection, not a heritable disorder. The relevant "genetics" are microbial: bacterial adhesin/pilus genes (e.g., sortase-dependent pilus loci in Actinomyces oris; fim fimbrial genes) that mediate coaggregation and biofilm formation (PMID: 31929180; PMID: 9524453), and virulence factors of companion organisms such as A. actinomycetemcomitans (PMID: 10522226).

5. Environmental Information

  • Environmental factors: Foreign bodies are central — the IUD is the paradigmatic example (PMID: 3526779; PMID: 6481117); retained gallstones after laparoscopic cholecystectomy have caused intraperitoneal actinomycosis (PMID: 19886052); prior surgery/implants predispose to soft-tissue disease (PMID: 42717451).
  • Lifestyle factors: Smoking and poor dental hygiene (pulmonary form); alcohol; dental neglect (PMID: 25045274).
  • Infectious agents (NCBI Taxonomy): Actinomyces israelii (txid1659), A. meyeri, A. odontolyticus, A. naeslundii, A. viscosus, A. gerencseriae; reclassified species now include Schaalia turicensis (formerly A. turicensis, PMID: 42604646) and Actinomyces radingae (PMID: 41691170). Genus Actinomyces = NCBI txid1654. Companion organisms include Aggregatibacter actinomycetemcomitans, Streptococcus oralis, Finegoldia magna, and Staphylococcus spp.

6. Mechanism / Pathophysiology

Ordered causal chain (initiating lesion → clinical manifestation):

1. Actinomyces spp. colonize the oral/GI/genital mucosa as harmless commensals
│  (established; PMID 25045274)
▼
2. A mucosal barrier breach (dental disease/procedure, aspiration, IUD, trauma,
   surgery) LEADS TO translocation of the organism into normally sterile deep tissue
│  (established; PMID 24905109)
▼
3. In tissue, Actinomyces coaggregates with companion bacteria via fimbrial/
   sortase-dependent pilus adhesins, RESULTING IN a polymicrobial biofilm
│  (established in oral plaque model; PMID 31929180, 9524453)
▼
4. Companion organisms breach the epithelial cell barrier, FACILITATING deeper
   tissue penetration and synergistic invasion
│  (demonstrated for A. actinomycetemcomitans; PMID 10522226 — inferred to
│   generalize to actinomycosis biofilms)
▼
5. The biofilm macroscopically forms "sulfur granules"; the organism is phagocytosed
   but NOT killed (facultative intracellular survival), RESULTING IN persistence
│  (established; PMID 2228706)
▼
6. Persistent antigen elicits a chronic granulomatous/suppurative host response with
   antigen–antibody–fibrin deposition → the Splendore–Hoeppli phenomenon
│  (established; PMID 18976399, 38077408)
▼
7. Chronic inflammation LEADS TO abscess formation, dense fibrosis, and sinus tracts
   that cross anatomical tissue planes
│  (established; PMID 6481117, 25045274)
▼
8. The infiltrative fibro-inflammatory mass MANIFESTS clinically as a chronic,
   cancer-mimicking lesion at the affected site
   │
   ├──► localized disease → curable with prolonged penicillin (>90% favorable)
   └──► hematogenous/contiguous spread → disseminated/CNS disease (~11% fatal)
      (PMID 41712794; PMID 37269006; PMID 38077408)

Molecular pathways / cellular processes. The dominant biology is bacterial biofilm formation (GO:0042710) via cell–cell adhesion (GO:0098609) and sortase-mediated pilus assembly, plus a host granulomatous inflammatory response (GO:0002532) and defense response to bacterium (GO:0042742). There is no canonical human oncogenic/degenerative signaling cascade (Wnt, MAPK, mTOR) involved — this is an infectious/inflammatory, not a signaling, disease.

Immune involvement. Neutrophilic suppuration surrounds granules; macrophages phagocytose but fail to kill the organism (facultative intracellular parasitism, PMID: 2228706); a humoral response contributes antigen–antibody complexes to Splendore–Hoeppli material (PMID: 18976399). Cell types: neutrophils (CL:0000775), macrophages (CL:0000235), plasma cells (CL:0000786), fibroblasts (CL:0000057), and mucosal epithelial cells (CL:0000066) at the breach site.

Tissue damage mechanisms. Chronic suppuration, necrosis, and reactive fibrosis; extension across tissue planes rather than respecting fascial boundaries. Metabolic/biochemical: Actinomyces is a fermentative anaerobe; disease favors low-oxygen (devitalized/necrotic) tissue niches. No specific enzyme deficiency or metabolomic signature is established for this infection.

7. Anatomical Structures Affected

Tissue/cell level: primarily mucosal epithelium (breach site) and connective tissue/bone at the infection focus; the lesion is a mixed inflammatory infiltrate. Subcellular: the phagosome/phagolysosome of host macrophages is relevant (survival within phagocytes; GO:0045335 phagocytic vesicle). Lateralization: typically unilateral/focal at the site of breach; disseminated disease is multifocal.

8. Temporal Development

  • Onset: Predominantly adult (mean ~44 y in CNS series; ~55 y in transplant series). Onset is insidious/chronic, over weeks to months.
  • Progression: Slow and progressive if untreated. Diagnostic delay averages ~110 days (range 30–540) (PMID: 41712794); the interval from transplant to infection reached a median of 104 months (PMID: 30055044). Disease crosses tissue planes rather than following formal staging; there is no cancer-style staging system.
  • Duration/remission: With appropriate antibiotics ± surgery, the disease is curable, though relapse is described (hence the long treatment course). Remission is treatment-induced; untreated disease does not spontaneously resolve. Recurrence propensity is noted for reclassified species (S. turicensis, PMID: 42604646).
  • Critical periods: Early recognition (before CNS/disseminated spread) is the key window; failure to recognize the disease early "may result in drastic complications" (PMID: 20458215).

9. Inheritance and Population

  • Epidemiology: Rare. Historically cited incidence ~1 per 300,000/year in the pre-antibiotic era, now lower. Prevalence among renal transplant recipients was 0.02% (PMID: 30055044). Among IUD users, cervical Actinomyces-like organism prevalence is 2–22.6% depending on device and duration (PMID: 3526779; PMID: 6529911). In wild cervids, focal granulomatous lymphadenitis occurs in 0.3–1.3% (PMID: 19617472).
  • Inheritance: Not heritable — no inheritance pattern, penetrance, expressivity, anticipation, mosaicism, founder effect, consanguinity role, or carrier frequency applies.
  • Demographics: Male predominance in some series (57% male in CNS, PMID: 37269006; overall M:F historically ~3:1 for cervicofacial/thoracic), but pelvic disease is essentially exclusive to women (IUD-related). Geographic distribution is worldwide with no strong endemicity; regional shifts track IUD introduction (e.g., post-1990 rise in Romania, PMID: 19886052).

10. Diagnostics

  • Histopathology (cornerstone): sulfur granules with radiating filaments surrounded by Splendore–Hoeppli material within suppurative/granulomatous inflammation and reactive fibrosis; Gram-positive, non-acid-fast filaments (PMID: 25045274; PMID: 42717451; PMID: 23008010). Grocott/PAS stains highlight filaments (PMID: 38077408).
  • Microbiology: prolonged anaerobic culture (gold standard but high false-negative rate) (PMID: 25045274; PMID: 24905109; PMID: 28684963).
  • Molecular: 16S rRNA gene PCR/sequencing (PMID: 38077408; PMID: 30572823) and metagenomic next-generation sequencing (mNGS) — increasingly decisive for indolent/reclassified species (PMID: 42604646; PMID: 41691170).
  • Cytology (Pap smear): actinomyces-like organisms on cervical smear signal IUD-associated colonization — but beware "pseudoactinomyces" mimics that can cause false alarm (PMID: 21323418).
  • Imaging: CT/MRI/FDG-PET typically show an infiltrative, hypermetabolic mass — helpful for extent but cannot distinguish from malignancy, often prompting biopsy/surgery (PMID: 42007821; PMID: 38077408).
  • Genetic/omics diagnostics: Not applicable (no host genetic test). No newborn/carrier screening.
  • Differential diagnosis: malignancy (carcinoma, sarcoma, lymphoma), tuberculosis and other granulomatous infections, nocardiosis, Crohn's disease, fungal disease. Nocardiosis is a key mimic distinguished by acid-fastness and aerobic growth (PMID: 42007821; PMID: 24905109).

11. Outcome / Prognosis

  • Localized disease: excellent. Favorable outcome in 16/17 (94%) (PMID: 41712794); 6/7 transplant patients fully recovered (PMID: 30055044). Low antimicrobial resistance supports high cure rates (PMID: 24905109).
  • CNS/disseminated disease: worse. Case-fatality ~11%, neurological sequelae ~22%; combined surgery + antibiotics improves survival (adjusted OR 0.14) (PMID: 37269006). Fatal hepatic/pericardial and pulmonary/CNS cases are documented (PMID: 33346982; PMID: 19581170).
  • Prognostic factors: anatomical site (CNS worst), extent (disseminated ~19.5% in CNS series), timeliness of diagnosis, and completeness of surgical resection. Adjunctive corticosteroids helped in constrictive pericardial disease (PMID: 38077408).
  • Complications: sinus tracts, fistulae (e.g., to colon/small bowel), osteomyelitis, constrictive pericarditis, brain abscess, sepsis/multiorgan failure.

12. Treatment

  • Pharmacotherapy (first line): high-dose penicillin G (IV) followed by oral amoxicillin/penicillin V, for 6–12 months, shortenable to ~3 months after complete surgical resection (PMID: 25045274). NCIT: Penicillin G (C61785), Amoxicillin (C287). Alternatives for penicillin allergy: doxycycline, clindamycin, macrolides, ceftriaxone; carbapenems (ertapenem, meropenem) used in polymicrobial/resistant contexts (PMID: 41691170; PMID: 41871568); clindamycin used for S. turicensis (PMID: 42604646).
  • Surgical/interventional: drainage/resection of abscesses, debridement of necrotic bone, excision of infiltrative masses; ~43% of transplant cases required surgery (PMID: 30055044). Surgery is both diagnostic and therapeutic and shortens antibiotic duration.
  • Foreign-body removal: IUD removal is therapeutic and preventive for pelvic disease (PMID: 6529911).
  • Adjunctive: corticosteroids in selected inflammatory complications (constrictive pericarditis) (PMID: 38077408).
  • Advanced/experimental therapeutics: Not applicable — no gene, cell, RNA, targeted, or immunotherapy is used; this is a classically antibiotic-responsive infection. No pharmacogenomic considerations are established.
  • Adverse events: vancomycin nephrotoxicity noted when broad empiric regimens are used before diagnosis (PMID: 41871568).

13. Prevention

  • Primary: good oral/dental hygiene; smoking cessation; careful management of intra-oral and abdominal foreign bodies; avoiding retained surgical material (PMID: 25045274; PMID: 19886052).
  • IUD management: timely device exchange; preference for copper over inert devices (lower ALO prevalence); removal clears asymptomatic colonization in 100% within 6–12 months without antibiotics (PMID: 6529911).
  • Secondary: cervical Pap-smear surveillance for ALO in IUD users, with awareness of pseudoactinomyces to avoid unnecessary device removal (PMID: 21323418); early biopsy of mass lesions to shorten diagnostic delay.
  • Tertiary: complete surgical resection plus prolonged antibiotics to prevent relapse and complications.
  • Immunization / genetic counseling / public health vector control: Not applicable — no vaccine, no heritable risk, no vector.

14. Other Species / Natural Disease

  • Taxonomy of affected hosts: Homo sapiens (txid9606); cattle Bos taurus (txid9913, "lumpy jaw"); white-tailed deer Odocoileus virginianus and other wild cervids (PMID: 2228706; PMID: 19617472).
  • Natural disease / veterinary relevance: Bovine actinomycosis (mandibular "lumpy jaw," typically A. bovis) is a classic veterinary disease of economic importance; granulomatous lymphadenitis with Splendore–Hoeppli material occurs in wild cervids (93% of affected nodes) (PMID: 19617472).
  • Comparative pathology: the Splendore–Hoeppli phenomenon and sulfur-granule biofilm architecture are conserved across host species, indicating a conserved host–pathogen interaction rather than a species-specific mechanism.
  • Transmission / zoonosis: Not zoonotic — no animal-to-human or human-to-human transmission; each host acquires disease from its own endogenous commensal flora after a barrier breach.

15. Model Organisms

  • Dedicated genetic disease models: None — because there is no host genetic defect, there are no knockout/knock-in/transgenic disease models (no MGI/RGD/ZFIN disease-model entries).
  • Relevant experimental systems: In vitro biofilm/coaggregation models of Actinomyces oris with Streptococcus oralis recapitulate the adhesin/pilus-mediated plaque-seeding step (PMID: 31929180; PMID: 9524453); epithelial-barrier invasion models with A. actinomycetemcomitans model deep-tissue penetration (PMID: 10522226). Natural animal disease (cattle, cervids) serves as a comparative model of the granulomatous host response (PMID: 19617472).
  • Limitations: These in vitro systems model early colonization/biofilm and barrier crossing but do not reproduce the full chronic granulomatous mass, Splendore–Hoeppli reaction, or clinical mimicry of malignancy.

Mechanistic Model / Interpretation

Actinomycosis is best understood as a breach-plus-biofilm disease. A single unifying model accounts for every clinical form:

Step Category Evidence (PMID) Certainty
Commensal colonization Infectious agent 25045274 Established
Mucosal breach (dental/IUD/aspiration/surgery/trauma) Environmental trigger 24905109; 3526779 Established
Adhesin/pilus coaggregation → polymicrobial biofilm Molecular/cellular 31929180; 9524453 Established (oral model)
Companion-organism epithelial penetration Cellular process 10522226 Demonstrated for companion; inferred for actinomycosis
Phagocytosis without killing (facultative intracellular survival) Immune evasion 2228706 Established
Splendore–Hoeppli granulomatous response Immune/tissue 18976399; 38077408 Established
Abscess, fibrosis, tissue-plane-crossing sinus tracts Tissue damage 6481117; 25045274 Established
Cancer-mimicking mass → localized (curable) vs disseminated/CNS (~11% fatal) Clinical outcome 41712794; 37269006 Established

The model explains the disease's paradoxes: it is caused by a harmless bug (so it is not "caught"), yet is aggressive locally (biofilm + immune evasion); it is highly antibiotic-sensitive (so cure rates exceed 90%), yet frequently misdiagnosed and delayed (so it still kills, especially in the CNS). The two therapeutic levers — antibiotics (kill the persistent biofilm organisms) and surgery/foreign-body removal (debulk the biofilm and remove the nidus) — act directly on the two mechanistic pillars.

Evidence Base

PMID Title (abbrev.) Role
25045274 Actinomycosis: etiology, clinical features, diagnosis, treatment, and management Anchor review: etiology, three forms, diagnosis, treatment
24905109 Abdominal actinomycosis: differential to colon carcinoma / Crohn's Mucosal-breach requirement; culture false-negatives
41712794 Retrospective series of 17 Diagnostic delay (110 d); 94% favorable outcome
37269006 CNS actinomycosis systematic review (n=118) 11% fatality; surgery+antibiotics OR 0.14
30055044 Actinomycosis in renal transplant recipients Prevalence 0.02%; amoxicillin outcomes
2228706 Cervicofacial actinomycosis in children Facultative intracellular parasite; cattle comparative
18976399 Mucocutaneous Splendore–Hoeppli phenomenon Immune-response histology
38077408 Cardiac/pericardial actinomycosis 16S confirmation; Splendore–Hoeppli; steroids adjunct
3526779 Actinomyces in cervical smears of IUD users 6.99% ALO prevalence; duration effect
6529911 IUD removal and cervical colonization Reversibility (100%); inert>copper risk
28684963 Pelvic Actinomycosis systematic review IUD dominance; histology-after-surgery route
19617472 Granulomatous lymphadenitis in wild cervids Natural animal disease; 93% Splendore–Hoeppli
31929180 S. oralis PitA pilus Adhesin/pilus biofilm seeding with A. oris
10522226 Virulence factors of A. actinomycetemcomitans Epithelial-barrier breaching by companion organism
9524453 Inhibitors of bacterial adhesion Actinomyces adhesins evade host inhibitors
42717451, 42007821, 42501997, 42287450, 41871568, 25301047, 23008010 Case series (multi-site) Tumor mimicry across anatomy
42604646, 41691170 S. turicensis / A. radingae osteomyelitis mNGS diagnosis; reclassified species; polymicrobial
33346982, 20458215, 19581170 Fatal hepatic/pulmonary/CNS cases Severe-end outcomes
21323418 Pseudoactinomyces in cervical mucus Diagnostic pitfall
6481117, 19886052 Abdominal actinomycosis in IUD users Fistulae; foreign-body nidus; epidemiologic shift

Concordance: The literature is highly internally consistent. No paper in the reviewed set contradicts the breach-plus-biofilm model; disagreements are limited to relative frequencies, which vary by referral pattern and era.

Limitations and Knowledge Gaps

  1. Evidence quality. The base is dominated by case reports, retrospective series, and systematic reviews of case-level data. There are no randomized controlled trials of antibiotic duration or the surgery-vs-medical-alone question; treatment durations (6–12 months) are consensus-based, not trial-proven.
  2. Incidence uncertainty. True population incidence/prevalence is poorly quantified because the disease is rare, underdiagnosed, and often reclassified microbiologically (species renaming to Schaalia, Winkia, etc.).
  3. Mechanistic inference. The epithelial-barrier-breach step is directly demonstrated for the companion organism A. actinomycetemcomitans (PMID: 10522226) and inferred to generalize to Actinomyces biofilms in vivo; there is no direct in-vivo human demonstration of the invasion sequence.
  4. Host-response detail. Why some hosts contain the organism and others develop invasive disease is not molecularly resolved; there is no validated host biomarker or genetic susceptibility signal.
  5. Omics void. There are no transcriptomic, proteomic, or metabolomic signatures of human actinomycosis in the reviewed literature — an omics-based diagnostic/prognostic gap.
  6. Model organisms. No genetic animal model exists (appropriately, as the disease is non-genetic), which limits controlled mechanistic dissection to in-vitro biofilm systems and opportunistic natural animal disease.

Proposed Follow-up Experiments / Actions

  1. Prospective diagnostic-yield study of mNGS vs culture vs histology across anatomical sites, to formalize the emerging role of metagenomic sequencing and reduce the ~110-day diagnostic delay (PMID: 41712794; PMID: 42604646).
  2. Registry-based comparative-effectiveness analysis of antibiotic duration (3 vs 6 vs 12 months) stratified by completeness of surgical resection, to test the "shortenable to 3 months after resection" hypothesis (PMID: 25045274).
  3. In-vivo biofilm invasion model (organoid or animal) to directly test the inferred companion-organism epithelial-breach step and quantify Actinomyces–partner synergy (PMID: 10522226; PMID: 31929180).
  4. Host-response profiling (transcriptomic/proteomic on sulfur-granule tissue) to identify why phagocytes fail to kill the organism and to seek adjunctive immunomodulatory targets (PMID: 2228706).
  5. CNS actinomycosis prospective cohort to validate the surgery+antibiotics survival benefit (adjusted OR 0.14) and define optimal timing (PMID: 37269006).
  6. IUD device-material trial / surveillance confirming lower colonization with modern copper/hormonal devices and defining optimal exchange intervals (PMID: 6529911).

Report generated by autonomous scientific discovery agent. Evidence attributed only to abstracts/citation snippets confirmed during investigation. Ontology suggestions (HPO/GO/CL/UBERON/NCIT/MONDO/NCBI Taxon) are provided as curation aids and should be verified against current ontology releases.

Artifacts

Reference Validation

Checked with linkml-reference-validator 0.3.0rc1.

Outcome Count
References checked 31
Resolved 31
Unresolved (possible confabulation) 0
Unverifiable 0
Quoted claims checked 1
Quoted claims found in source 1
Quoted claims not found in source 0
References weighed for topical relevance 31
On topic 22
Off topic 0

All extracted references resolved successfully.

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome Count
Terms checked 34
Resolved 34
Unresolved (possible confabulation) 0
Obsolete 0
Unverifiable 0
Terms whose name was checked 16
Terms named correctly 7
Terms named as a different term 4
Terms whose name is worth a second look 5

Terms the report names something else

These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:

  • MONDO:0001580 (2 mentions) - the report calls it "actinomycosis"; MONDO calls it lacrimal duct cancer
  • HP:0100279 (1 mention) - the report calls it "Fistula"; HP calls it Ulcerative colitis
  • UBERON:0002048 (1 mention) - the report calls it "Thoracic/pulmonary: lung"; UBERON calls it lung**
  • UBERON:0001155 (1 mention) - the report calls it "Abdominopelvic: ileocecal region/colon"; UBERON calls it colon**

Terms whose name is worth a second look

The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:

  • HP:0002664 (1 mention) - the report calls it "Neoplasm — mimic"; HP calls it Neoplasm
  • HP:0011897 (1 mention) - the report calls it "Neutrophilia"; HP calls it Increased total neutrophil count, and lists "Neutrophilia" among its other names
  • GO:0042710 (1 mention) - the report calls it "bacterial biofilm formation"; GO calls it biofilm formation
  • GO:0002532 (1 mention) - the report calls it "granulomatous inflammatory response"; GO calls it production of molecular mediator involved in inflammatory response
  • UBERON:0000955 (1 mention) - the report calls it "CNS: brain"; UBERON calls it brain**